What is brompheniramine (Bromphed)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brompheniramine (Bromphed): A First-Generation Antihistamine

Brompheniramine (Bromphed) is a first-generation antihistamine that acts as an H1-receptor antagonist with significant anticholinergic properties, used primarily for treating symptoms of allergic rhinitis, common cold, and upper airway cough syndrome. 1

Mechanism of Action

  • Brompheniramine belongs to the alkylamine class of antihistamines and works by competing with histamine for H1-receptor sites on effector cells, antagonizing allergic responses including vasodilation, increased vascular permeability, and increased mucus secretion 1
  • Unlike newer generation antihistamines, brompheniramine has significant anticholinergic (drying) effects that contribute to its efficacy in treating rhinorrhea, particularly in non-allergic conditions 2
  • It also possesses sedative properties due to its ability to cross the blood-brain barrier 1, 3

Pharmacokinetics

  • Brompheniramine is well absorbed from the gastrointestinal tract with peak plasma concentrations reached in approximately 3-5 hours after oral administration 1, 4
  • It has a long half-life of approximately 24.9 hours and a large volume of distribution (11.7 L/kg) 4
  • Elimination occurs primarily through urinary excretion, mostly as products of biodegradation, with the liver being the main site of metabolic transformation 1

Clinical Applications

  • Upper Airway Cough Syndrome (UACS): First-generation antihistamines like brompheniramine are recommended as first-line empiric therapy for UACS due to their anticholinergic effects 2
  • Common Cold: Brompheniramine has proven efficacy in reducing rhinorrhea, sneezing, and cough associated with rhinovirus colds 2, 5
  • Allergic Rhinitis: Effective for treating symptoms of allergic rhinitis, particularly when combined with decongestants like pseudoephedrine 2
  • Post-viral Upper Respiratory Infections: Often combined with pseudoephedrine for treating cough and nasal symptoms associated with post-viral URIs 2

Dosing

  • For adults, typical dosing is 4 mg every 4-6 hours or 8-12 mg of sustained-release formulations twice daily 3
  • Often combined with pseudoephedrine (as in Bromphed-D) for enhanced decongestant effects 2

Advantages Over Newer Antihistamines

  • First-generation antihistamines like brompheniramine are more effective than newer generation antihistamines for treating cough associated with the common cold due to their anticholinergic properties 2
  • The ACCP guidelines specifically recommend first-generation antihistamines over newer generation nonsedating antihistamines for treating cough associated with common cold 2

Side Effects and Precautions

  • Sedation is the primary side effect, with potential for impaired performance in tasks requiring alertness 3, 4
  • Performance impairment may occur without subjective awareness of sedation, potentially affecting driving and school performance 2
  • Anticholinergic effects include dry mouth, dry eyes, constipation, urinary retention, and potential exacerbation of narrow-angle glaucoma 2
  • Sustained-release preparations may have similar performance-impairing effects as immediate-release forms 3
  • Use with caution in patients with glaucoma, prostatic hypertrophy, or urinary retention 2

Comparative Efficacy

  • Brompheniramine has similar affinity for muscarinic receptors as chlorpheniramine, making them comparable in anticholinergic effects 6
  • Both are significantly more anticholinergic than second-generation antihistamines like terfenadine 6
  • When combined with pseudoephedrine, brompheniramine provides effective relief of both histamine-mediated symptoms and nasal congestion 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The pharmacokinetics and antihistaminic effects of brompheniramine.

The Journal of allergy and clinical immunology, 1982

Research

Efficacy of brompheniramine maleate for the treatment of rhinovirus colds.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.